# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1954566 | B | Inhibition of PIM1 | 57 | single protein format | Scientific Literature | |||
2. | ALA2114730 | F | PubChem BioAssay. Cell Proliferation Assay against the TMD8 Cell Line (Caspase readout at 16 hrs). (Class of assay: confirmatory) | 270 | assay format | PubChem BioAssays | |||
3. | ALA2114770 | F | PubChem BioAssay. qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway. (Class of assay: confirmatory) | 267 | assay format | PubChem BioAssays | |||
4. | ALA2114779 | F | PubChem BioAssay. Cytotoxicity counterscreen for NFkB agonists and antagonists. (Class of assay: confirmatory) | 224 | assay format | PubChem BioAssays | |||
5. | ALA2114803 | F | PubChem BioAssay. Cell Proliferation Assay against the TMD8 Cell Line (Caspase readout at 8 hrs). (Class of assay: confirmatory) | 226 | assay format | PubChem BioAssays | |||
6. | ALA2149353 | B | Inhibition of human ERG | Homo sapiens | 1 | single protein format | Scientific Literature | ||
7. | ALA2184774 | B | Inhibition of haspin | 1 | single protein format | Scientific Literature | |||
8. | ALA2184775 | B | Inhibition of FLT3 | 1 | single protein format | Scientific Literature | |||
9. | ALA2184776 | B | Competitive inhibition of PIM3 in presence of ATP | 1 | single protein format | Scientific Literature | |||
10. | ALA2184777 | B | Competitive inhibition of PIM2 in presence of ATP | 3 | single protein format | Scientific Literature | |||
11. | ALA2184780 | B | Competitive inhibition of PIM1 in presence of ATP | 5 | single protein format | Scientific Literature | |||
12. | ALA2354304 | F | PubChem BioAssay. qHTS for small molecule inhibitors of Yes1 kinase: Confirmatory screen on the cherrypicks. (Class of assay: confirmatory) | 17 | assay format | PubChem BioAssays | |||
13. | ALA2411892 | B | Inhibition of Yes1 (unknown origin) by [gamma-33P]-ATP radiolabeled enzyme activity assay | Homo sapiens | 10 | single protein format | Scientific Literature | ||
14. | ALA2411893 | B | Inhibition of Yes1 (unknown origin) assessed as kinase-dependent enzymatic production of ADP from ATP using coupled luminescence-based reaction by ADP-Glo kinase assay | Homo sapiens | 10 | single protein format | Scientific Literature | ||
15. | ALA3106176 | B | Inhibition of PIM3 (unknown origin) | Homo sapiens | 30 | single protein format | Scientific Literature | ||
16. | ALA3106177 | B | Inhibition of PIM1 (unknown origin) | Homo sapiens | 27 | single protein format | Scientific Literature | ||
17. | ALA3106178 | B | Inhibition of PIM2 (unknown origin) | Homo sapiens | 31 | single protein format | Scientific Literature | ||
18. | ALA3215013 | F | PubChem BioAssay. qHTS for small molecule inhibitors of Yes1 kinase: Primary Screen. (Class of assay: confirmatory) | 502 | assay format | PubChem BioAssays | |||
19. | ALA3214970 | F | PubChem BioAssay. qHTS Assay for Identifying Gametocytocidal Compounds. (Class of assay: confirmatory) | 1,094 | assay format | PubChem BioAssays | |||
20. | ALA3301365 | A | ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma at 37C for >5hrs. Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound. | Homo sapiens | 1,614 | cell-free format | AstraZeneca Deposited Data |